Medindia
About ▼ Careers Internship MedBlog Contact us
English (US) ▼
Medindia
LOGIN REGISTER
Advertisement

CryoLife Announces Enrollment of First Patients in BioGlue® Clinical Trial in China

Tuesday, November 7, 2017 Clinical Trials News
Advertisement
Sponsored Post and Backlink Submission


Latest Press Release on Clinical Trials News

NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia
SHANGHAI and LEXINGTON , Mass.  , May 8, 2024 /PRNewswire/ -- NeuShen Therapeutics (the "Company"), a clinical-stage global biotechnology company dedicated to pioneering treatmen...
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
STATEN ISLAND, N.Y. , May 2, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a ne...
PLT Health Solutions Granted Broad Ranging Cognitive Health Claims from Health Canada Based on Clinical Study Results
Nutricog ® Cognitive Performance Complex has been Clinically Demonstrated to Improve Memory, Increase Learning Rate and Capacity, Enhance Focus and Concentration and Improve Overall B...
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib
SHANGHAI , April 8, 2024 /PRNewswire/ -- 9 April 2024 (Beijing Time) , Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced the completion of patient enrollment f...
Vivet Therapeutics Doses First Patient in Cohort 2 in Phase 1/2 GATEWAY Clinical Trial for Treatment of Wilson Disease
Dosing of first patient completed in Cohort 2 following Data Monitoring Committee approval to proceed Encouraging safety, tolerability and early pharmacodynamic changes observed i...
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close